Encyclopedia

  • Prazosin hydrochloride (cas 19237-84-4)
  • Add time:07/31/2019         Source:sciencedirect.com

    Publisher SummaryThis chapter discusses the prazosin hydrochloride. Prazosin hydrochloride was synthesized and developed by the Medicinal Chemistry Laboratories of Pfizer Inc. Prazosin hydrochloride was introduced as a novel antihypertensive agent with pharmacological activity attributed to arteriolar vasodilation. The anhydrous alpha form is the preferred polymorphic form of prazosin hydrochloride due to its nonhygroscopic characteristic leading to ease of handling and formulation. The prazosin hydrochloride alpha polymorphic form was used throughout the clinical efficacy studies. Its trade names are minipress, hypovase, and sinetens. Prazosin hydrochloride is a white to off-white, crystalline, odorless powder. The infrared absorption spectrum of prazosin hydrochloride was obtained as a KBr pellet using a Perkin-Elmer model 21 infrared spectrophotometer.

    We also recommend Trading Suppliers and Manufacturers of Prazosin hydrochloride (cas 19237-84-4). Pls Click Website Link as below: cas 19237-84-4 suppliers


    Prev:Structural characterization of Prazosin hydrochloride (cas 19237-84-4) and prazosin free base
    Next: Activity dependent internalization of the glutamate transporter GLT-1 requires calcium entry through the NCX sodium/calcium exchanger)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View